Jeffrey Perl




Dr Jeffrey Perl is a staff nephrologist at, St Michael’s Hospital in Toronto and Associate Professor of Medicine at the University of Toronto. He received his Master of Science in Epidemiology from The Harvard School for Public Health. He is a prior recipient of The John Maher Young Investigator Award by the International Society for Peritoneal Dialysis and has received several teaching awards at The University of Toronto and St. Michael’s Hospital. He serves as the current editor-in-chief of Peritoneal Dialysis International.  He is also chair of the home dialysis subcommittee of the American Society of Nephrology COVID-19 response team. His primary research interests and clinical practice focuses on improving the survival and quality of life for patients on home dialysis. Dr. Perl is a primary investigator in The International Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) and principal investigator of the Optimizing the Prevention of Peritoneal Dialysis Associated Peritonitis in The United States (OPPUS) study.

Recent Publications

  1. Shah, AD, Perl, J. Peritoneal Dialysis International in 2023: What questions do you need answered?. Perit Dial Int. 2023;43 (1):3-4. doi: 10.1177/08968608221147750. PubMed PMID:36647560 .
  2. Boudville, N, McCullough, K, Bieber, B, Pisoni, R, Kanjanabuch, T, Kawanishi, H et al.. A different PET test: The relationship between pet ownership and peritonitis risk in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit Dial Int. 2023; :8968608221144450. doi: 10.1177/08968608221144450. PubMed PMID:36601674 .
  3. Al Sahlawi, M, Perl, J. Peritoneal Dialysis Peritonitis Outcomes: Getting to the Heart of the Matter. Kidney Int Rep. 2022;7 (11):2329-2331. doi: 10.1016/j.ekir.2022.09.023. PubMed PMID:36531896 PubMed Central PMC9751743.
  4. Lu, S, Al Sahlawi, M, Perl, J. Reducing polymicrobial and enteric peritonitis: a gut response. Nephrol Dial Transplant. 2022; :. doi: 10.1093/ndt/gfac326. PubMed PMID:36509419 .
  5. Perl, J, Harel, Z, Nessim, SJ. Peritoneal Fluid Analysis in Peritoneal Dialysis-Associated Peritonitis. JAMA. 2022; :. doi: 10.1001/jama.2022.21289. PubMed PMID:36355384 .
  6. Purisinsith, S, Kanjanabuch, P, Phannajit, J, Kanjanabuch, T, Puapatanakul, P, Johnson, DW et al.. Oral Health-Related Quality of Life, A Proxy of Poor Outcomes in Patients on Peritoneal Dialysis. Kidney Int Rep. 2022;7 (10):2207-2218. doi: 10.1016/j.ekir.2022.07.008. PubMed PMID:36217510 PubMed Central PMC9546760.
  7. Davies, S, Zhao, J, McCullough, KP, Kim, YL, Wang, AY, Badve, SV et al.. International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival. Kidney360. 2022;3 (5):872-882. doi: 10.34067/KID.0006922021. PubMed PMID:36128496 PubMed Central PMC9438413.
  8. Young, EW, Zhao, J, Pisoni, RL, Piraino, BM, Shen, JI, Boudville, N et al.. Peritoneal Dialysis-Associated Peritonitis Trends Using Medicare Claims Data, 2013-2017. Am J Kidney Dis. 2023;81 (2):179-189. doi: 10.1053/j.ajkd.2022.07.010. PubMed PMID:36108889 .
  9. Lopes, MB, Karaboyas, A, Zhao, J, Johnson, DW, Kanjanabuch, T, Wilkie, M et al.. Association of single and serial measures of serum phosphorus with adverse outcomes in patients on peritoneal dialysis: results from the international PDOPPS. Nephrol Dial Transplant. 2023;38 (1):193-202. doi: 10.1093/ndt/gfac249. PubMed PMID:36029279 PubMed Central PMC9869855.
  10. Shen, JI, Cho, Y, Manera, KE, Brown, F, Dong, J, Al Sahlawi, M et al.. Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology-Peritoneal Dialysis Consensus Workshop Report. Kidney Int Rep. 2022;7 (8):1737-1744. doi: 10.1016/j.ekir.2022.05.020. PubMed PMID:35967119 PubMed Central PMC9366360.
Search PubMed

Affiliations & Other Activities

  • Nephrologist, Division of Nephrology, St. Michael’s Hospital
  • Assistant Professor of Medicine, University of Toronto
  • Chair, International Society of Nephrology’s Young Nephrologists Committee